Cargando…
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells
Pancreatic cancer remains an intractable cancer with a poor five-year survival rate, which requires new therapeutic modalities based on the biology of pancreatic oncogenesis. Nuclear factor E2 related factor-2 (NRF2), a key cytoprotective nuclear transcription factor, regulates antioxidant productio...
Autores principales: | Duong, Hong-Quan, You, Kyu Sic, Oh, Seunghoon, Kwak, Sahng-June, Seong, Yeon-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618080/ https://www.ncbi.nlm.nih.gov/pubmed/28671577 http://dx.doi.org/10.3390/antiox6030052 |
Ejemplares similares
-
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells
por: DUONG, HONG-QUAN, et al.
Publicado: (2014) -
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH(High) Melanoma-Initiating Cells
por: Sarvi, Sana, et al.
Publicado: (2018) -
The expression of ALDH1 in cervical carcinoma
por: Yao, Tingting, et al.
Publicado: (2011) -
ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017) -
Global Deletion of ALDH1A1 and ALDH1A2 Genes Does Not Affect Viability but Blocks Spermatogenesis
por: Topping, Traci, et al.
Publicado: (2022)